Inovio shares update on COVID-19 vaccine, and its financial outlook – The Philadelphia Inquirer

In March, during a public meeting with President Donald Trump and pharma executives, Kim touted Inovios innovative, 21st-century platform that enabled it to whip up its vaccine candidate in a mere three hours. Soon after, an analyst who is shorting Inovios stock accused the firm of serial stock promotion. And soon after that, two separate groups of shareholders filed lawsuits in federal court in Pennsylvania, accusing Kim and Inovio of exaggerated claims and financial improprieties.

Read the original post:

Inovio shares update on COVID-19 vaccine, and its financial outlook - The Philadelphia Inquirer

Related Posts
Tags: